NextCure, Inc.
NXTC
$0.375
-$0.0108-2.80%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.55M | 3.73M | 4.08M | 4.36M | 3.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.46M | 12.50M | 16.49M | 15.76M | 15.79M |
| Operating Income | -12.46M | -12.50M | -16.49M | -15.76M | -15.79M |
| Income Before Tax | -11.60M | -11.54M | -15.40M | -17.11M | -14.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.60M | -11.54M | -15.40M | -17.11M | -14.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.60M | -11.54M | -15.40M | -17.11M | -14.47M |
| EBIT | -12.46M | -12.50M | -16.49M | -15.76M | -15.79M |
| EBITDA | -11.78M | -11.80M | -15.79M | -14.97M | -14.97M |
| EPS Basic | -0.41 | -0.41 | -0.55 | -0.61 | -0.52 |
| Normalized Basic EPS | -0.26 | -0.26 | -0.34 | -0.33 | -0.32 |
| EPS Diluted | -0.41 | -0.41 | -0.55 | -0.61 | -0.52 |
| Normalized Diluted EPS | -0.26 | -0.26 | -0.34 | -0.33 | -0.32 |
| Average Basic Shares Outstanding | 28.01M | 27.98M | 27.97M | 27.90M | 27.90M |
| Average Diluted Shares Outstanding | 28.01M | 27.98M | 27.97M | 27.90M | 27.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
